Trikona Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 9.65 Cr
as on 23-10-2024
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.50 Cr
as on 23-10-2024
- Satisfied Charges ₹ 1.30 Cr
as on 23-10-2024
- Revenue 67.30%
(FY 2023)
- Profit 39.15%
(FY 2023)
- Ebitda 49.47%
(FY 2023)
- Net Worth -12.53%
(FY 2023)
- Total Assets -12.04%
(FY 2023)
About Trikona Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 9.65 Cr.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹1.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sura Reddy and Sunil Chandra serve as directors at the Company.
- CIN/LLPIN
U24233TG2016PTC102838
- Company No.
102838
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Jan 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Trikona Pharmaceuticals Private Limited offer?
Trikona Pharmaceuticals Private Limited offers a wide range of products and services, including Nutritional Supplements, Folic Acid Tablets, Vitamin C Tablet.
Who are the key members and board of directors at Trikona Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sura Reddy  | Director | 21-Jan-2016 | Current |
| Sunil Chandra | Director | 21-Jan-2016 | Current |
Financial Performance and Corporate Structure Insights of Trikona Pharmaceuticals.
Trikona Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 67.3% increase. The company also saw a substantial improvement in profitability, with a 39.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trikona Pharmaceuticals?
In 2022, Trikona Pharmaceuticals had a promoter holding of 98.76% and a public holding of 1.24%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
P H Diagnostic Centre Private LimitedActive 29 years 7 monthsSura Reddy and Sunil Chandra are mutual person
Medinova Diagnostic Services LimitedActive 31 years 9 monthsSura Reddy and Sunil Chandra are mutual person
Vijaya Diagnostic Centre LimitedActive 22 years 6 monthsSura Reddy and Sunil Chandra are mutual person
Vdc Diagnostics (Karnataka) LlpActive 11 years 2 monthsSura Reddy and Sunil Chandra are mutual person
- Medinova Millennium Mri Services LlpActive 10 years 29 days
Sura Reddy and Sunil Chandra are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Idbi Bank Limited Creation Date: 30 Sep 2024 | ₹1.50 Cr | Open |
Idbi Bank Limited Creation Date: 13 Dec 2016 | ₹1.30 Cr | Satisfied |
How Many Employees Work at Trikona Pharmaceuticals?
Trikona Pharmaceuticals has a workforce of 144 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trikona Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trikona Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
